Literature DB >> 2580910

Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production.

D J Volkman, M Popovic, R C Gallo, A S Fauci.   

Abstract

The ability of human T cell leukemia/lymphoma virus (HTLV)-I to alter the function of infected T lymphocytes was examined directly by investigating the properties of an antigen-specific T cell clone before and after transformation with HTLV-I. Following infection, the T4 antigen-specific clone manifested a tenfold increase in its surface interleukin 2 (IL 2) receptor (Tac) density and acquired the viral determinants p19, p24, and 4D12 not present in the uninfected clone. Prior to infection, the T cell clone responded to antigen stimulation in the presence of histocompatible antigen-presenting cells with proliferation and secretion of multiple lymphokines, including IL 2, B cell growth factor (BCGF), B cell differentiation factor (BCDF), and interferon-gamma (IFN-gamma). Following infection, the T cell clone both proliferated and produced constitutively three of these lymphokines (BCGF, BCDF, and IFN-gamma) in the absence of accessory cells or antigen. Co-cultivation with any accessory cells regardless of histocompatibility resulted in increased proliferation and lymphokine production. IL 2 production by the HTLV-I-transformed cell, however, could not be detected. Similarly, the uninfected clone was able to provide B cell help for Ig production only when stimulated with both histocompatible cells and antigen. In contrast, the infected cell provided T cell help to B cells in an unregulated manner, independent of antigen or histocompatibility. Thus, functions such as the induction of proliferation, B cell help, and lymphokine production, which are finely regulated in uninfected antigen-specific T cell clones, became indiscriminant after HTLV-I infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580910

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood cultures.

Authors:  C D'Onofrio; C D Pesce; T Fontana; F Ciprani; E Bonmassar; R Caliŏ
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus.

Authors:  Akiko Niinuma; Masaya Higuchi; Masahiko Takahashi; Masayasu Oie; Yuetsu Tanaka; Fumitake Gejyo; Nobuyuki Tanaka; Kazuo Sugamura; Li Xie; Patrick L Green; Masahiro Fujii
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

Authors:  R Yarchoan; H G Guo; M Reitz; A Maluish; H Mitsuya; S Broder
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Cell receptors for the mammalian reovirus: reovirus-specific T-cell hybridomas can become persistently infected and undergo autoimmune stimulation.

Authors:  N Matsuzaki; V S Hinshaw; B N Fields; M I Greene
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway.

Authors:  T Akagi; K Shimotohno
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Human T-cell leukemia virus type I infection of CD4+ or CD8+ cytotoxic T-cell clones results in immortalization with retention of antigen specificity.

Authors:  D V Faller; M A Crimmins; S J Mentzer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Selection of HTLV-I positive clones is prevented by prostaglandin A in infected cord blood cultures.

Authors:  C D'Onofrio; E Alvino; E Garaci; E Bonmassar; M G Santoro
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

Review 8.  Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis.

Authors:  Masaya Higuchi; Masahiro Fujii
Journal:  Retrovirology       Date:  2009-12-17       Impact factor: 4.602

9.  Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon.

Authors:  C D'Onofrio; C F Perno; P Mazzetti; G Graziani; R Calio'; E Bonmassar
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.